日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Validation Study of Scores Predicting Hepatocellular Carcinoma Risk in Chronic Hepatitis B Patients Treated With Nucleos(t)ide Analogues

核苷(酸)类似物治疗慢性乙型肝炎患者肝细胞癌风险预测评分的验证研究

Inoue, Jun; Minami, Shinichiro; Abe, Kazumichi; Kida, Mami; Haga, Hiroaki; Iino, Chikara; Numao, Hiroshi; Kuroda, Hidekatsu; Ninomiya, Masashi; Tsuruoka, Mio; Sato, Kosuke; Onuki, Masazumi; Sawahashi, Satoko; Ouchi, Keishi; Watanabe, Kengo; Akahane, Takehiro; Kobayashi, Tomoo; Ohira, Hiromasa; Ueno, Yoshiyuki; Masamune, Atsushi

Effect of Proteinuria Before Lenvatinib Administration on Treatment Response After Atezolizumab Bevacizumab Combination Therapy

乐伐替尼治疗前蛋白尿对阿特珠单抗联合贝伐珠单抗治疗反应的影响

Ochi, Hironori; Kurosaki, Masayuki; Tanaka, Takaaki; Tamaki, Nobuharu; Tsuchiya, Kaoru; Yasui, Yutaka; Marusawa, Hiroyuki; Tada, Toshifumi; Nakamura, Shinichiro; Akahane, Takehiro; Okamoto, Eisuke; Kobashi, Haruhiko; Arai, Hirotaka; Nonogi, Michiko; Izumi, Namiki

Effect of Pemafibrate on Metabolic Dysfunction-Associated Steatotic Liver Disease: A Nationwide Multicenter Study

培马贝特对代谢功能障碍相关脂肪肝疾病的影响:一项全国多中心研究

Komiyama, Yasuyuki; Tamaki, Nobuharu; Tsuji, Keiji; Mori, Nami; Mashiba, Toshie; Ochi, Hironori; Kobashi, Haruhiko; Ogawa, Chikara; Nonogi, Michiko; Yoshida, Hideo; Akahane, Takehiro; Kondo, Masahiko; Kasai, Toyotaka; Fujii, Hideki; Uchida, Yasushi; Arai, Hirotaka; Tsuchiya, Kaoru; Izumi, Namiki; Kurosaki, Masayuki

Effect of treatment periods on efficacy of glecaprevir and pibrentasvir in chronic hepatitis C: A nationwide, prospective, multicenter study

治疗周期对格卡瑞韦和哌仑他韦治疗慢性丙型肝炎疗效的影响:一项全国性、前瞻性、多中心研究

Morita, Atsuhiro; Tamaki, Nobuharu; Kobashi, Haruhiko; Mori, Nami; Tsuji, Keiji; Takaki, Shintaro; Hasebe, Chitomi; Akahane, Takehiro; Ochi, Hironori; Mashiba, Toshie; Urawa, Naohito; Fujii, Hideki; Mitsuda, Akeri; Kondo, Masahiko; Ogawa, Chikara; Uchida, Yasushi; Narita, Ryoichi; Marusawa, Hiroyuki; Kubotsu, Yoshihito; Matsushita, Tomomichi; Shigeno, Masaya; Yoshida, Hideo; Tanaka, Katsuaki; Okamoto, Eisuke; Kasai, Toyotaka; Ishii, Toru; Okada, Kazuhiko; Kurosaki, Masayuki; Izumi, Namiki

Necessity for surveillance for hepatocellualr carcinoma in older patients with chronic hepatitis C who achieved sustained virological response

对于已获得持续病毒学应答的慢性丙型肝炎老年患者,有必要进行肝细胞癌监测。

Ishido, Shun; Tamaki, Nobuharu; Kurosaki, Masayuki; Mori, Nami; Tsuji, Keiji; Hasebe, Chitomi; Mashiba, Toshie; Ochi, Hironori; Yasui, Yutaka; Akahane, Takehiro; Furuta, Koichiro; Kobashi, Haruhiko; Fujii, Hideki; Ishii, Toru; Marusawa, Hiroyuki; Kondo, Masahiko; Kusakabe, Atsunori; Yoshida, Hideo; Uchida, Yasushi; Tada, Toshifumi; Nakamura, Shinichiro; Mitsuda, Akari; Ogawa, Chikara; Arai, Hirotaka; Murohisa, Toshimitsu; Uebayashi, Minoru; Izumi, Namiki

Hepatocellular Carcinoma Risk Assessment for Patients With Advanced Fibrosis After Eradication of Hepatitis C Virus

丙型肝炎病毒根除后晚期纤维化患者的肝细胞癌风险评估

Tamaki, Nobuharu; Kurosaki, Masayuki; Yasui, Yutaka; Mori, Nami; Tsuji, Keiji; Hasebe, Chitomi; Joko, Kouji; Akahane, Takehiro; Furuta, Koichiro; Kobashi, Haruhiko; Kimura, Hiroyuki; Yagisawa, Hitoshi; Marusawa, Hiroyuki; Kondo, Masahiko; Kojima, Yuji; Yoshida, Hideo; Uchida, Yasushi; Tada, Toshifumi; Nakamura, Shinichiro; Yasuda, Satoshi; Toyoda, Hidenori; Loomba, Rohit; Izumi, Namiki

Non-Achievement of Alanine Aminotransferase Normalization Associated with the Risk of Hepatocellular Carcinoma during Nucleos(t)ide Analogue Therapies: A Multicenter Retrospective Study

核苷(酸)类似物治疗期间丙氨酸氨基转移酶未恢复正常与肝细胞癌风险相关:一项多中心回顾性研究

Inoue, Jun; Kobayashi, Tomoo; Akahane, Takehiro; Kimura, Osamu; Sato, Kosuke; Ninomiya, Masashi; Iwata, Tomoaki; Takai, Satoshi; Kisara, Norihiro; Sato, Toshihiro; Nagasaki, Futoshi; Miura, Masahito; Nakamura, Takuya; Umetsu, Teruyuki; Sano, Akitoshi; Tsuruoka, Mio; Onuki, Masazumi; Niitsuma, Hirofumi; Masamune, Atsushi; Therme Study Group

A validation study of after direct-acting antivirals recommendation for surveillance score for the development of hepatocellular carcinoma in patients with hepatitis C virus infection who had received direct-acting antiviral therapy and achieved sustained virological response

一项验证性研究旨在评估直接抗病毒药物治疗后,丙型肝炎病毒感染患者肝细胞癌发生监测评分推荐值在接受直接抗病毒药物治疗并达到持续病毒学应答后的应用价值。

Tada, Toshifumi; Kurosaki, Masayuki; Tamaki, Nobuharu; Yasui, Yutaka; Mori, Nami; Tsuji, Keiji; Hasebe, Chitomi; Joko, Koji; Akahane, Takehiro; Furuta, Koichiro; Kobashi, Haruhiko; Kimura, Hiroyuki; Yagisawa, Hitoshi; Marusawa, Hiroyuki; Kondo, Masahiko; Kojima, Yuji; Yoshida, Hideo; Uchida, Yasushi; Nakamura, Shinichiro; Izumi, Namiki

Real-world long-term analysis of daclatasvir plus asunaprevir in patients with hepatitis C virus infection

达克拉他韦联合阿舒那韦治疗丙型肝炎病毒感染患者的真实世界长期分析

Fujii, Hideki; Kimura, Hiroyuki; Hasebe, Chitomi; Akahane, Takehiro; Satou, Takashi; Kusakabe, Atsunori; Kojima, Yuji; Kondo, Masahiko; Marusawa, Hiroyuki; Kobashi, Haruhiko; Tsuji, Keiji; Ogawa, Chikara; Uchida, Yasushi; Joko, Kouji; Mitsuda, Akeri; Kurosaki, Masayuki; Izumi, Namiki

General evaluation score for predicting the development of hepatocellular carcinoma in patients with advanced liver fibrosis associated with hepatitis C virus genotype 1 or 2 after direct-acting antiviral therapy

预测丙型肝炎病毒基因1型或2型相关晚期肝纤维化患者在接受直接抗病毒治疗后发生肝细胞癌的总体评估评分

Tada, Toshifumi; Kurosaki, Masayuki; Tamaki, Nobuharu; Yasui, Yutaka; Mori, Nami; Tsuji, Keiji; Hasebe, Chitomi; Joko, Koji; Akahane, Takehiro; Furuta, Koichiro; Kobashi, Haruhiko; Fujii, Hideki; Ishii, Toru; Marusawa, Hiroyuki; Kondo, Masahiko; Kojima, Yuji; Yoshida, Hideo; Uchida, Yasushi; Nakamura, Shinichiro; Izumi, Namiki